Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 130

1.

Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma.

Casula M, Colombino M, Manca A, Caracò C, Botti G, Ascierto PA, Lissia A, Cossu A, Palmieri G; Italian Melanoma Intergroup (IMI).

J Invest Dermatol. 2016 Jun 2. pii: S0022-202X(16)31332-X. doi: 10.1016/j.jid.2016.05.103. [Epub ahead of print] No abstract available.

PMID:
27265006
2.

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme).

Avallone A, Piccirillo MC, Aloj L, Nasti G, Delrio P, Izzo F, Di Gennaro E, Tatangelo F, Granata V, Cavalcanti E, Maiolino P, Bianco F, Aprea P, De Bellis M, Pecori B, Rosati G, Carlomagno C, Bertolini A, Gallo C, Romano C, Leone A, Caracò C, de Lutio di Castelguidone E, Daniele G, Catalano O, Botti G, Petrillo A, Romano GM, Iaffaioli VR, Lastoria S, Perrone F, Budillon A.

BMC Cancer. 2016 Feb 8;16:69. doi: 10.1186/s12885-016-2102-y.

3.

Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: Results of the BRANCH trial.

Avallone A, Pecori B, Bianco F, Aloj L, Tatangelo F, Romano C, Granata V, Marone P, Leone A, Botti G, Petrillo A, Caracò C, Iaffaioli VR, Muto P, Romano G, Comella P, Budillon A, Delrio P.

Oncotarget. 2015 Oct 6;6(30):30394-407. doi: 10.18632/oncotarget.4724.

4.

Role of (68)Ga-DOTATATE PET/CT in patients with multiple endocrine neoplasia type 1 (MEN1).

Lastoria S, Marciello F, Faggiano A, Aloj L, Caracò C, Aurilio M, D'Ambrosio L, Di Gennaro F, Ramundo V, Camera L, De Luca L, Fonti R, Napolitano V, Colao A.

Endocrine. 2016 Jun;52(3):488-94. doi: 10.1007/s12020-015-0702-y. Epub 2015 Aug 5.

PMID:
26242621
5.

Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy.

Mozzillo N, Simeone E, Benedetto L, Curvietto M, Giannarelli D, Gentilcore G, Camerlingo R, Capone M, Madonna G, Festino L, Caracò C, Di Monta G, Marone U, Di Marzo M, Grimaldi AM, Mori S, Ciliberto G, Ascierto PA.

Oncoimmunology. 2015 May 22;4(6):e1008842. eCollection 2015 Jun.

6.

Clinicopathologic features and surgical management of primary umbilical melanoma: a case series.

Di Monta G, Caracò C, Marone U, Grimaldi AM, Anniciello AM, Di Marzo M, Simeone E, Mori S.

BMC Res Notes. 2015 Apr 15;8:147. doi: 10.1186/s13104-015-1096-x.

7.

Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.

Mozzillo N, Pasquali S, Santinami M, Testori A, Di Marzo M, Crispo A, Patuzzo R, Verrecchia F, Botti G, Montella M, Rossi CR, Caracò C.

Eur J Surg Oncol. 2015 Jul;41(7):823-9. doi: 10.1016/j.ejso.2015.02.005. Epub 2015 Mar 11.

PMID:
25800935
8.

Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas.

Manca A, Lissia A, Capone M, Ascierto PA, Botti G, Caracò C, Stanganelli I, Colombino M, Sini M, Cossu A, Palmieri G.

J Transl Med. 2015 Jan 28;13:37. doi: 10.1186/s12967-015-0401-8.

9.

Vemurafenib beyond progression in a patient with metastatic melanoma: a case report.

Grimaldi AM, Simeone E, Palla M, Festino L, Caracò C, Mozzillo N, Petrillo A, Muto P, Ascierto PA.

Anticancer Drugs. 2015 Apr;26(4):464-8. doi: 10.1097/CAD.0000000000000206.

PMID:
25622086
10.

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid--short Radiotherapy--rectum 3rd trial).

Avallone A, Piccirillo MC, Delrio P, Pecori B, Di Gennaro E, Aloj L, Tatangelo F, D'Angelo V, Granata C, Cavalcanti E, Maurea N, Maiolino P, Bianco F, Montano M, Silvestro L, Terranova Barberio M, Roca MS, Di Maio M, Marone P, Botti G, Petrillo A, Daniele G, Lastoria S, Iaffaioli VR, Romano G, Caracò C, Muto P, Gallo C, Perrone F, Budillon A.

BMC Cancer. 2014 Nov 24;14:875. doi: 10.1186/1471-2407-14-875.

11.

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

Grimaldi AM, Simeone E, Giannarelli D, Muto P, Falivene S, Borzillo V, Giugliano FM, Sandomenico F, Petrillo A, Curvietto M, Esposito A, Paone M, Palla M, Palmieri G, Caracò C, Ciliberto G, Mozzillo N, Ascierto PA.

Oncoimmunology. 2014 May 14;3:e28780. eCollection 2014.

12.

Number of excised lymph nodes as a quality assurance measure for lymphadenectomy in melanoma.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Macripò G, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

JAMA Surg. 2014 Jul;149(7):700-6. doi: 10.1001/jamasurg.2013.5676.

PMID:
24804856
13.

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced melanoma.

Simeone E, Gentilcore G, Giannarelli D, Grimaldi AM, Caracò C, Curvietto M, Esposito A, Paone M, Palla M, Cavalcanti E, Sandomenico F, Petrillo A, Botti G, Fulciniti F, Palmieri G, Queirolo P, Marchetti P, Ferraresi V, Rinaldi G, Pistillo MP, Ciliberto G, Mozzillo N, Ascierto PA.

Cancer Immunol Immunother. 2014 Jul;63(7):675-83. doi: 10.1007/s00262-014-1545-8. Epub 2014 Apr 3. Erratum in: Cancer Immunol Immunother. 2014 Nov;63(11):1233.

PMID:
24695951
14.

Nonsentinel lymph node status in patients with cutaneous melanoma: results from a multi-institution prognostic study.

Pasquali S, Mocellin S, Mozzillo N, Maurichi A, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M, Rossi CR.

J Clin Oncol. 2014 Mar 20;32(9):935-41. doi: 10.1200/JCO.2013.50.7681. Epub 2014 Feb 10.

15.

Radioimmunotherapy with Tenarad, a 131I-labelled antibody fragment targeting the extra-domain A1 of tenascin-C, in patients with refractory Hodgkin's lymphoma.

Aloj L, D'Ambrosio L, Aurilio M, Morisco A, Frigeri F, Caraco' C, Di Gennaro F, Capobianco G, Giovannoni L, Menssen HD, Neri D, Pinto A, Lastoria S.

Eur J Nucl Med Mol Imaging. 2014 May;41(5):867-77. doi: 10.1007/s00259-013-2658-6. Epub 2014 Jan 17.

PMID:
24435772
16.

The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

Ann Oncol. 2014 Jan;25(1):240-6. doi: 10.1093/annonc/mdt510.

17.

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis.

Caracò C, Mozzillo N, Marone U, Simeone E, Benedetto L, Di Monta G, Di Cecilia ML, Botti G, Ascierto PA.

BMC Cancer. 2013 Dec 1;13:564. doi: 10.1186/1471-2407-13-564.

18.

Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.

Lastoria S, Piccirillo MC, Caracò C, Nasti G, Aloj L, Arrichiello C, de Lutio di Castelguidone E, Tatangelo F, Ottaiano A, Iaffaioli RV, Izzo F, Romano G, Giordano P, Signoriello S, Gallo C, Perrone F.

J Nucl Med. 2013 Dec;54(12):2062-9. doi: 10.2967/jnumed.113.119909. Epub 2013 Oct 17.

19.

Surgical management of sentinel lymph node biopsy outside major nodal basin in patients with cutaneous melanoma.

Caracò C, Marone U, Di Monta G, Aloj L, Caracò C, Anniciello A, Lastoria S, Botti G, Mozzillo N.

Ann Surg Oncol. 2014 Jan;21(1):300-5. doi: 10.1245/s10434-013-3285-y. Epub 2013 Oct 1.

PMID:
24081802
20.

Electrochemotherapy as "new standard of care" treatment for cutaneous Kaposi's sarcoma.

Di Monta G, Caracò C, Benedetto L, La Padula S, Marone U, Tornesello ML, Buonaguro FM, Simeone E, Ascierto PA, Mozzillo N.

Eur J Surg Oncol. 2014 Jan;40(1):61-6. doi: 10.1016/j.ejso.2013.09.002. Epub 2013 Sep 12.

PMID:
24075826
Items per page

Supplemental Content

Loading ...
Write to the Help Desk